Management of Chronic Hypertension Following Intracerebral Hemorrhage

Critical Care Nursing Quarterly
Edward T Van MatreKeaton S Smetana

Abstract

Acute blood pressure control after a cerebrovascular event is integral in the immediate care of these patients to preserve perfusion to ischemic areas and prevent intracerebral bleeding. The majority of patients with ischemic stroke or intracerebral hemorrhage (ICH) present with preexisting hypertension and therefore require a treatment plan after the acute phase. The presence of chronic hypertension after ICH has often been discussed as a modifiable risk factor for recurrent events. Clinical evidence is relatively lacking for clinicians to understand the extent of blood pressure lowering and the optimal agents to use in this setting. Limited data exist describing the long-term management of hypertension in patients after cerebrovascular events. This review provides nurses with a summary of the available literature on long-term blood pressure management to minimize the risk of secondary ICH and ischemic stroke. It focuses on oral antihypertensive medications available in the United States that may be utilized to manage chronic hypertension immediately after the postacute phase of care to lower blood pressure and to improve long-term outcomes.

References

Nov 11, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G G KrishnaR G Narins
Jan 1, 1988·Annals of the New York Academy of Sciences·A Scriabine, W van den Kerckhoff
Dec 1, 1987·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·D ConenU C Dubach
Jun 1, 1981·British Heart Journal·P J RossA H Henderson
Dec 1, 1980·Clinical Pharmacology and Therapeutics·T M LuddenM S Lin
Mar 1, 1993·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·P A van Zwieten, M Pfaffendorf
Jul 5, 2002·Current Controlled Trials in Cardiovascular Medicine·Chris L Bryson CL, Bruce M Psaty BM MD PhD
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Jun 21, 2003·Stroke; a Journal of Cerebral Circulation·Joachim SchraderUNKNOWN Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group
Oct 24, 2003·American Journal of Hypertension·Mari Konishi NishizakaDavid A Calhoun
Oct 24, 2003·The New England Journal of Medicine·Brian L StromDan Pettitt
Nov 10, 2005·Proceedings·Amy Barreras, Cheryle Gurk-Turner
Dec 3, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Théophile Godfraind
Apr 22, 2006·Stroke; a Journal of Cerebral Circulation·Hisatomi ArimaUNKNOWN PROGRESS Collaborative Group
Aug 30, 2008·The New England Journal of Medicine·Salim YusufUNKNOWN PRoFESS Study Group
Apr 26, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Christopher Chang, M Eric Gershwin
Sep 8, 2011·The Journal of Clinical Hypertension·William H Frishman, Elijah Saunders
Oct 25, 2011·Indian Journal of Pharmacology·Sushmita Purkayastha, Peter B Raven
Jul 5, 2012·Alcoholism, Clinical and Experimental Research·Meghan L O'NeilDennis D Rasmussen
Oct 12, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Jayantee KalitaBishwanath Kumar
May 30, 2013·The New England Journal of Medicine·Craig S AndersonUNKNOWN INTERACT2 Investigators
Jun 6, 2013·American Journal of Hypertension·Carole L WhiteUNKNOWN SPS3 Investigators
Nov 5, 2013·Journal of the Neurological Sciences·J P ShoupL H Sansing
Nov 19, 2013·Journal of Cardiovascular Pharmacology and Therapeutics·George C RoushMichael E Ernst
Apr 2, 2014·The Annals of Pharmacotherapy·Toni L Ripley, Joseph J Saseen
May 15, 2015·Current Molecular Pharmacology·Jörg StriessnigAlexandra Pinggera
Jun 9, 2016·The New England Journal of Medicine·Adnan I QureshiUNKNOWN ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network
Jul 1, 2017·Heart·James P SheppardRichard J McManus
Mar 31, 2018·Journal of the American College of Cardiology·Franz H MesserliStefano F Rimoldi
Oct 26, 2018·Hypertension·Robert M CareyUNKNOWN American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council

❮ Previous
Next ❯

Citations

Feb 23, 2020·Critical Care Nursing Quarterly·Keaton S SmetanaCasey C May

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.